DOCSLIB.ORG

Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum" (2020)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School March 2020 Mass Spectrometry Discovery-Based Proteomics to Examine Anti- Aging Effects of the Nutraceutical NT-020 in Rat Serum Samantha M. Portis University of South Florida Follow this and additional works at: https://scholarcommons.usf.edu/etd Part of the Bioinformatics Commons, and the Neurosciences Commons Scholar Commons Citation Portis, Samantha M., "Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum" (2020). Graduate Theses and Dissertations. https://scholarcommons.usf.edu/etd/8279 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Mass Spectrometry Discovery-Based Proteomics to Examine Anti-Aging Effects of the Nutraceutical NT-020 in Rat Serum by Samantha M. Portis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Medical Sciences with a concentration in Neuroscience Department of Molecular Pharmacology and Physiology College of Medicine University of South Florida Major Professor: Paul R. Sanberg, Ph.D., D.Sc Co-Major Professor: Paula C. Bickford, Ph.D. Kevin Nash, Ph.D. Dominic D’Agostino, Ph.D. Brent Small, Ph.D. Date of Approval: March 28, 2020 Keywords: aging, proteome, serum, inflammation, bioinformatics Copyright © 2020, Samantha M. Portis Dedication I dedicate this work to my family, Alan, Candace, Carolyn, and Jimmy, my brother, Patrick, and my partner, Will. Without your unfailing support and encouragement, this would not have been possible. Thank you for your love and support throughout this process. Acknowledgements This work was made possible by the guidance and support of my mentors, Dr. Paula C. Bickford and Dr. Paul R. Sanberg. I would also like to thank Dr. Dominic D’Agostino, Dr. Brent Small, and Dr. Kevin Nash for your advice, recommendations, and feedback during the development of this project. I also want to extend my sincere gratitude to Dr. Dale Chaput from the Proteomics Core Facility at the College of Arts and Sciences, who helped me immensely on this project, and my good friend Dr. Jared Ehrhart who was an invaluable source of support during my first few years of graduate school. I would also like to thank Dr. Edwin Weeber, who has moved on to another institution, but who nonetheless served as a valuable member of my committee while he was here and was one of the finest professors with whom I have studied. Thank you all for your advice and encouragement throughout my burgeoning academic career. Table of Contents List of Tables ................................................................................................................................. ii List of Figures .............................................................................................................................. iv Abstract ........................................................................................................................................ vi Chapter 1: Introduction ................................................................................................................ 1 Aging ................................................................................................................................ 1 Cell Autonomous and Cell Non-Autonomous Changes: Effects on the Stem Cell Niche ................................................................................................................... 4 Parabiosis Studies ................................................................................................ 5 Sex Differences .................................................................................................... 9 Graft Studies ...................................................................................................... 11 Nutraceuticals for Aging and Age-related Degenerative Diseases ................................ 12 Polyphenolic Compounds and Diet .................................................................... 14 NT-020 ............................................................................................................... 17 Summary of Approaches and Project Aims ................................................................... 28 Chapter 2: Proteomics ............................................................................................................... 30 Mass Spectrometry and Proteomics .............................................................................. 30 Tissue-Specific Proteomics Using Serum ...................................................................... 33 Sample Preparation and Albumin Depletion....................................................... 34 LC-MS/MS .......................................................................................................... 38 Analysis .............................................................................................................. 38 Chapter 3: Effects of Nutraceutical Intervention on Serum Proteins in Aged Rats .................... 40 Abstract .......................................................................................................................... 40 Introduction .................................................................................................................... 41 Materials and Methods ................................................................................................... 44 Animals ............................................................................................................... 44 Sample Preparation ............................................................................................ 45 LC-MS/MS .......................................................................................................... 46 Analysis .............................................................................................................. 46 Results ........................................................................................................................... 47 Change of Protein Expression as a Function of Age .......................................... 47 NT-020 Counteracts Upregulated Immune Response in Aged Rat Serum ........ 47 Autophagy Pathway Protein Cathepsin A is Upregulated with NT-020 .............. 48 Macrophage Stimulating 1 Decreases with NT-020 ........................................... 49 Complement System Proteins were Altered by NT-020 ..................................... 50 Discussion ...................................................................................................................... 51 Chapter 4: Conclusions and Future Directions .......................................................................... 71 Conclusions .................................................................................................................... 71 Overview ............................................................................................................ 71 i Aging and NT-020 .............................................................................................. 72 Serum Data ........................................................................................................ 73 Autophagy and Aging ......................................................................................... 75 Macrophage Stimulating 1 and Complement Proteins ....................................... 76 Apolipoproteins ................................................................................................... 77 Future Directions ............................................................................................................ 78 Study Limitations ................................................................................................ 78 Future Studies .................................................................................................... 79 References ................................................................................................................................. 81 Appendix A: The Role of Glycogen Synthase Kinase-3 Signaling in Neruodevelopment and Fragile X Syndrome .............................................................................................. 91 Appendix B: GFAP Expression and Social Deficits in Transgenic Mice Overexpressing Human sAPPα .................................................................................................... 100 Appendix C: Potential Autoepitope within the Extracellular Region of Contactin-Associated Protein-like 2 in Mice .......................................................................................... 114 ii List of Tables Table 1. Expression of proteins in old rat serum compared to young ........................................ 56 Table 2. Expression of proteins in old NT-020 serum versus old control ................................... 56 Table 3. Full list of proteins detected ......................................................................................... 56 iii List of Figures Figure 1. Prevalence of disease by age ........................................................................................ 1 Figure 2. NT-020 promotes CD34+ cell proliferation .................................................................
Load more

Recommended publications
  • Frequent Expression Loss of Inter-Alpha-Trypsin Inhibitor Heavy Chain (ITIH) Genes in Multiple Human Solid Tumors: a Systematic Expression Analysis
    Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25. Postprint available at: http://www.zora.uzh.ch University of Zurich Posted at the Zurich Open Repository and Archive, University of Zurich. Zurich Open Repository and Archive http://www.zora.uzh.ch Originally published at: BMC Cancer 2008, 8:25. Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2008 Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25. Postprint available at: http://www.zora.uzh.ch Posted at the Zurich Open Repository and Archive, University of Zurich. http://www.zora.uzh.ch Originally published at: BMC Cancer 2008, 8:25. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis Abstract BACKGROUND: The inter-alpha-trypsin inhibitors (ITI) are a family of plasma protease inhibitors, assembled from a light chain - bikunin, encoded by AMBP - and five homologous heavy chains (encoded by ITIH1, ITIH2, ITIH3, ITIH4, and ITIH5), contributing to extracellular matrix stability by covalent linkage to hyaluronan.
    [Show full text]
  • Supplementary Information Changes in the Plasma Proteome At
    Supplementary Information Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer’s disease Julia Muenchhoff1, Anne Poljak1,2,3, Anbupalam Thalamuthu1, Veer B. Gupta4,5, Pratishtha Chatterjee4,5,6, Mark Raftery2, Colin L. Masters7, John C. Morris8,9,10, Randall J. Bateman8,9, Anne M. Fagan8,9, Ralph N. Martins4,5,6, Perminder S. Sachdev1,11,* Supplementary Figure S1. Ratios of proteins differentially abundant in asymptomatic carriers of PSEN1 and APP Dutch mutations. Mean ratios and standard deviations of plasma proteins from asymptomatic PSEN1 mutation carriers (PSEN1) and APP Dutch mutation carriers (APP) relative to reference masterpool as quantified by iTRAQ. Ratios that significantly differed are marked with asterisks (* p < 0.05; ** p < 0.01). C4A, complement C4-A; AZGP1, zinc-α-2-glycoprotein; HPX, hemopexin; PGLYPR2, N-acetylmuramoyl-L-alanine amidase isoform 2; α2AP, α-2-antiplasmin; APOL1, apolipoprotein L1; C1 inhibitor, plasma protease C1 inhibitor; ITIH2, inter-α-trypsin inhibitor heavy chain H2. 2 A) ADAD)CSF) ADAD)plasma) B) ADAD)CSF) ADAD)plasma) (Ringman)et)al)2015)) (current)study)) (Ringman)et)al)2015)) (current)study)) ATRN↓,%%AHSG↑% 32028% 49% %%%%%%%%HC2↑,%%ApoM↓% 24367% 31% 10083%% %%%%TBG↑,%%LUM↑% 24256% ApoC1↓↑% 16565% %%AMBP↑% 11738%%% SERPINA3↓↑% 24373% C6↓↑% ITIH2% 10574%% %%%%%%%CPN2↓%% ↓↑% %%%%%TTR↑% 11977% 10970% %SERPINF2↓↑% CFH↓% C5↑% CP↓↑% 16566% 11412%% 10127%% %%ITIH4↓↑% SerpinG1↓% 11967% %%ORM1↓↑% SerpinC1↓% 10612% %%%A1BG↑%%% %%%%FN1↓% 11461% %%%%ITIH1↑% C3↓↑% 11027% 19325% 10395%% %%%%%%HPR↓↑% HRG↓% %%% 13814%% 10338%% %%% %ApoA1 % %%%%%%%%%GSN↑% ↓↑ %%%%%%%%%%%%ApoD↓% 11385% C4BPA↓↑% 18976%% %%%%%%%%%%%%%%%%%ApoJ↓↑% 23266%%%% %%%%%%%%%%%%%%%%%%%%%%ApoA2↓↑% %%%%%%%%%%%%%%%%%%%%%%%%%%%%A2M↓↑% IGHM↑,%%GC↓↑,%%ApoB↓↑% 13769% % FGA↓↑,%%FGB↓↑,%%FGG↓↑% AFM↓↑,%%CFB↓↑,%% 19143%% ApoH↓↑,%%C4BPA↓↑% ApoA4↓↑%%% LOAD/MCI)plasma) LOAD/MCI)plasma) LOAD/MCI)plasma) LOAD/MCI)plasma) (Song)et)al)2014)) (Muenchhoff)et)al)2015)) (Song)et)al)2014)) (Muenchhoff)et)al)2015)) Supplementary Figure S2.
    [Show full text]
  • The Oviductal Transcriptome Is Influenced by a Local Ovarian Effect in the Sow Rebeca López-Úbeda1,2, Marta Muñoz3, Luis Vieira1,2, Ronald H
    López-Úbeda et al. Journal of Ovarian Research (2016) 9:44 DOI 10.1186/s13048-016-0252-9 RESEARCH Open Access The oviductal transcriptome is influenced by a local ovarian effect in the sow Rebeca López-Úbeda1,2, Marta Muñoz3, Luis Vieira1,2, Ronald H. F. Hunter4, Pilar Coy1,2,5* and Sebastian Canovas1,2,5* Abstract Background: Oviducts participate in fertilization and early embryo development, and they are influenced by systemic and local circulation. Local functional interplay between ovary, oviduct and uterus is important, as deduced from the previously observed differences in hormone concentrations, presence of sperm, or patterns of motility in the oviduct after unilateral ovariectomy (UO). However, the consequences of unilateral ovariectomy on the oviductal transcriptome remain unexplored. In this study, we have investigated the consequences of UO in a higher animal model as the pig. Methods: The influence of UO was analyzed on the number of ovulations on the contra ovary, which was increased, and on the ipsilateral oviductal transcriptome. Microarray analysis was performed and the results were validated by PCR. Differentially expressed genes (DEGs) with a fold change ≥ 2andafalsediscoveryrateof10%were analyzed by Ingenuity Pathway Analysis (IPA) to identify the main biofunctions affected by UO. Results: Data revealed two principal effects in the ipsilateral oviduct after UO: i) down-regulation of genes involved in the survival of sperm in the oviduct and early embryonic development, and ii) up-regulation of genes involved in others functions as protection against external agents and tumors. Conclusions: Results showed that unilateral ovariectomy results in an increased number of ovulation points on the contra ovary and changes in the transcriptome of the ipsilateral oviduct with consequences on key biological process that could affect fertility output.
    [Show full text]
  • Downloaded and Searched Against the Dbest Database to Identify Ests
    BMC Genomics BioMed Central Research article Open Access A transcription map of the 6p22.3 reading disability locus identifying candidate genes Eric R Londin1, Haiying Meng2 and Jeffrey R Gruen*2 Address: 1Graduate Program in Genetics, State University of New York at Stony Brook, NY, USA and 2Yale Child Health Research Center, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA Email: Eric R Londin - [email protected]; Haiying Meng - [email protected]; Jeffrey R Gruen* - [email protected] * Corresponding author Published: 30 June 2003 Received: 22 April 2003 Accepted: 30 June 2003 BMC Genomics 2003, 4:25 This article is available from: http://www.biomedcentral.com/1471-2164/4/25 © 2003 Londin et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. reading disabilitydyslexia6p22.3In silicoESTs Abstract Background: Reading disability (RD) is a common syndrome with a large genetic component. Chromosome 6 has been identified in several linkage studies as playing a significant role. A more recent study identified a peak of transmission disequilibrium to marker JA04 (G72384) on chromosome 6p22.3, suggesting that a gene is located near this marker. Results: In silico cloning was used to identify possible candidate genes located near the JA04 marker. The 2 million base pairs of sequence surrounding JA04 was downloaded and searched against the dbEST database to identify ESTs. In total, 623 ESTs from 80 different tissues were identified and assembled into 153 putative coding regions from 19 genes and 2 pseudogenes encoded near JA04.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • Single Cell Analysis of Human Foetal Liver Captures the Transcriptional Profile of Hepatobiliary Hybrid Progenitors
    ARTICLE https://doi.org/10.1038/s41467-019-11266-x OPEN Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors Joe M. Segal 1,8, Deniz Kent1,8, Daniel J. Wesche2,3, Soon Seng Ng 1, Maria Serra1, Bénédicte Oulès 1, Gozde Kar4, Guy Emerton4, Samuel J.I. Blackford 1, Spyros Darmanis5, Rosa Miquel1, Tu Vinh Luong1, Ryo Yamamoto2, Andrew Bonham2, Wayel Jassem6, Nigel Heaton6, Alessandra Vigilante1, Aileen King7, Rocio Sancho 1, Sarah Teichmann 4, Stephen R. Quake5,9, Hiromitsu Nakauchi2,9 & S. Tamir Rashid1,2,9 1234567890():,; The liver parenchyma is composed of hepatocytes and bile duct epithelial cells (BECs). Controversy exists regarding the cellular origin of human liver parenchymal tissue generation during embryonic development, homeostasis or repair. Here we report the existence of a hepatobiliary hybrid progenitor (HHyP) population in human foetal liver using single-cell RNA sequencing. HHyPs are anatomically restricted to the ductal plate of foetal liver and maintain a transcriptional profile distinct from foetal hepatocytes, mature hepatocytes and mature BECs. In addition, molecular heterogeneity within the EpCAM+ population of freshly isolated foetal and adult human liver identifies diverse gene expression signatures of hepatic and biliary lineage potential. Finally, we FACS isolate foetal HHyPs and confirm their hybrid progenitor phenotype in vivo. Our study suggests that hepatobiliary progenitor cells pre- viously identified in mice also exist in humans, and can be distinguished from other par- enchymal populations, including mature BECs, by distinct gene expression profiles. 1 Centre for Stem Cells and Regenerative Medicine & Institute for Liver Studies, King’s College London, London WC2R 2LS, UK.
    [Show full text]
  • SNV Discovery and Functional Candidate Gene Identification For
    RESEARCH ARTICLE SNV discovery and functional candidate gene identification for milk composition based on whole genome resequencing of Holstein bulls with extremely high and low breeding values Shan Lin1, Hongyan Zhang1, Yali Hou2, Lin Liu3, Wenhui Li1, Jianping Jiang1, Bo Han1, 1 1 Shengli Zhang , Dongxiao SunID * a1111111111 1 Department of Animal Genetics and Breeding, College of Animal Science and Technology, Key Laboratory of Animal Genetics and Breeding of the Ministry of Agriculture, National Engineering Laboratory for Animal a1111111111 Breeding, China Agricultural University, Beijing, China, 2 Laboratory of Disease Genomics and Individualized a1111111111 Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China, 3 Beijing Dairy Cattle a1111111111 Center, Beijing, China a1111111111 * [email protected] Abstract OPEN ACCESS Citation: Lin S, Zhang H, Hou Y, Liu L, Li W, Jiang We have sequenced the whole genomes of eight proven Holstein bulls from the four half-sib J, et al. (2019) SNV discovery and functional or full-sib families with extremely high and low estimated breeding values (EBV) for milk pro- candidate gene identification for milk composition tein percentage (PP) and fat percentage (FP) using Illumina re-sequencing technology. based on whole genome resequencing of Holstein Consequently, 2.3 billion raw reads were obtained with an average effective depth of 8.1 . bulls with extremely high and low breeding values. × PLoS ONE 14(8): e0220629. https://doi.org/ After single nucleotide variant (SNV) calling, total 10,961,243 SNVs were identified, and 10.1371/journal.pone.0220629 57,451 of them showed opposite fixed sites between the bulls with high and low EBVs within Editor: Sujan Mamidi, HudsonAlpha Institute for each family (called as common differential SNVs).
    [Show full text]
  • Frequent Loss-Of-Heterozygosity in CRISPR-Cas9–Edited Early Human Embryos
    Frequent loss-of-heterozygosity in CRISPR-Cas9–edited COLLOQUIUM PAPER early human embryos Gregorio Alanis-Lobatoa, Jasmin Zohrenb, Afshan McCarthya, Norah M. E. Fogartya,c, Nada Kubikovad,e, Emily Hardmana, Maria Grecof, Dagan Wellsd,g, James M. A. Turnerb, and Kathy K. Niakana,h,1 aHuman Embryo and Stem Cell Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; bSex Chromosome Biology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; cCentre for Stem Cells and Regenerative Medicine, Guy’s Campus, King’s College London, SE1 9RT London, United Kingdom; dNuffield Department of Women’s and Reproductive Health, John Radcliffe Hospital, University of Oxford, OX3 9DU Oxford, United Kingdom; eJesus College, University of Oxford, OX1 3DW Oxford, United Kingdom; fAncient Genomics Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; gJuno Genetics, OX4 4GE Oxford, United Kingdom; and hThe Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, CB2 3EG Cambridge, United Kingdom Edited by Barbara J. Meyer, University of California, Berkeley, CA, and approved October 31, 2020 (received for review June 5, 2020) CRISPR-Cas9 genome editing is a promising technique for clinical homozygous WT embryos in both cases was not associated with applications, such as the correction of disease-associated alleles in use of the provided repair template for gene correction. Instead, somatic cells. The use of this approach has also been discussed in the authors suggest that in edited embryos the WT maternal the context of heritable editing of the human germ line. However, allele served as a template for the high-fidelity homology di- studies assessing gene correction in early human embryos report rected repair (HDR) pathway to repair the double-strand lesion low efficiency of mutation repair, high rates of mosaicism, and the caused by the Cas9 protein in the paternal allele (8).
    [Show full text]
  • Synonymous Variants Associated with Alzheimer Disease in Multiplex Families
    ARTICLE OPEN ACCESS Synonymous variants associated with Alzheimer disease in multiplex families Min Tang, PhD, Maria Eugenia Alaniz, PhD, Daniel Felsky, PhD, Badri Vardarajan, PhD, Correspondence Dolly Reyes-Dumeyer, BA, Rafael Lantigua, MD, Martin Medrano, MD, David A. Bennett, MD, Dr. Reitz [email protected] Philip L. de Jager, MD, PhD, Richard Mayeux, MD, MSc, Ismael Santa-Maria, PhD, and Christiane Reitz, MD, PhD Neurol Genet 2020;6:e450. doi:10.1212/NXG.0000000000000450 Abstract Objective Synonymous variants can lead to disease; nevertheless, the majority of sequencing studies conducted in Alzheimer disease (AD) only assessed coding variation. Methods To detect synonymous variants modulating AD risk, we conducted a whole-genome sequencing study on 67 Caribbean Hispanic (CH) families multiply affected by AD. Identified disease- associated variants were further assessed in an independent cohort of CHs, expression quanti- tative trait locus (eQTL) data, brain autopsy data, and functional experiments. Results Rare synonymous variants in 4 genes (CDH23, SLC9A3R1, RHBDD2, and ITIH2) segregated with AD status in multiplex families and had a significantly higher frequency in these families compared with reference populations of similar ancestry. In comparison to subjects without dementia, expression of CDH23 (β =0.53,p =0.006)andSLC9A3R1 (β =0.50,p = 0.02) was increased,andexpressionofRHBDD2 (β = −0.70, p = 0.02) decreased in individuals with AD at death. In line with this finding, increased expression of CDH23 (β = 0.26 ± 0.08, p = 4.9E-4) and decreased expression of RHBDD2 (β = −0.60 ± 0.12, p = 5.5E-7) were related to brain amyloid load (p = 0.0025).
    [Show full text]
  • A Serum Proteome Signature to Predict Mortality in Severe COVID-19 Patients
    Research Article A serum proteome signature to predict mortality in severe COVID-19 patients Franziska Vollmy¨ 1,2, Henk van den Toorn1,2, Riccardo Zenezini Chiozzi1,2, Ottavio Zucchetti3, Alberto Papi4, Carlo Alberto Volta5, Luisa Marracino6, Francesco Vieceli Dalla Sega7, Francesca Fortini7, Vadim Demichev8,9,10, Pinkus Tober-Lau11 , Gianluca Campo3,7, Marco Contoli4, Markus Ralser8,9, Florian Kurth11,12, Savino Spadaro5 , Paola Rizzo6,7, Albert JR Heck1,2 Here, we recorded serum proteome profiles of 33 severe Introduction COVID-19 patients admitted to respiratory and intensive care units because of respiratory failure. We received, for most pa- The coronavirus disease 2019 (COVID-19) pandemic caused by tients, blood samples just after admission and at two more later severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has time points. With the aim to predict treatment outcome, we fo- affected many people with a worrying fatality rate up to 60% for cused on serum proteins different in abundance between the critical cases. Not all people infected by the virus are affected group of survivors and non-survivors. We observed that a small equally. Several parameters have been defined that may influence panel of about a dozen proteins were significantly different in and/or predict disease severity and mortality, with age, gender, abundance between these two groups. The four structurally and body mass, and underlying comorbidities being some of the most functionally related type-3 cystatins AHSG, FETUB, histidine-rich well established. To
    [Show full text]
  • Mouse Itih2 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Itih2 Knockout Project (CRISPR/Cas9) Objective: To create a Itih2 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Itih2 gene (NCBI Reference Sequence: NM_010582 ; Ensembl: ENSMUSG00000037254 ) is located on Mouse chromosome 2. 21 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 21 (Transcript: ENSMUST00000042290). Exon 2~5 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 3.4% of the coding region. Exon 2~5 covers 13.44% of the coding region. The size of effective KO region: ~5894 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 21 Legends Exon of mouse Itih2 Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 1178 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 5 is aligned with itself to determine if there are tandem repeats.
    [Show full text]